CTXR · Citius Pharmaceuticals, Inc.
Substantial doubt about the company's ability to continue as a going concern.
“We will need to raise additional capital in the future to support our operations beyond November 2026, which raises substantial doubt about the Company's ability to continue as a going concern within one year after the date that the accompanying consolidated financial statements are issued.”View the 10-Q filed Aug 14, 2026
Positioning
Sep 18, 2026 · 23 days to expiryChain
Click any strike for greeks, breakeven and the calculator| Calls | Puts | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| OI | Vol | IV | Δ | Last | Strike | Last | Δ | IV | Vol | OI |
| 22 | 5 | — | — | $0.05 | $1.55 | — | — | 5 | 5 | |
| 1 | 6 | — | — | $0.10 | — | -0.935 | 419.2% | — | 0 | |
| 2 | 2 | — | — | $0.05 | — | -0.936 | 482.3% | — | 0 | |
About this data
Each contract's last price, volume, greeks, implied volatility and open interest belongs to the snapshot session shown in its details; unknown means the provider omitted the timestamp. This chain has mixed snapshot sessions · Aug 7, 2026–Aug 25, 2026; 2 unknown. Cross-contract positioning totals are shown only when every returned row has the same known session. Bid and ask are not included on this plan.
In-the-money strikes are tinted, deepening toward the money, and the bar beside each open-interest figure scales to the heaviest strike shown.